(4-Tetrazol-1-yl-phenyl)-acetic acid, 95.0%, 250mg

Benzo[d]oxazol-6-ylmethanol, 98%, 1g

N-(n-Heptyl)-n-octylamine, 97%, 1g

ETHYL-4-(5,6,7,8-TETRAHYDRO-1,8-NAPHTHYRIDIN-2-YL)BUTANOATE, 95.0%, 1g

6-CHLORO-1H-INDOL-5-OL, 95%, 250mg

3-Bromo-N-cyclopropyl-5-nitrobenzamide, 95.0%, 5g

Sulfate de nickel(II) hexahydraté, min 98 %, ultra pur, 500 g, emballage plastique.

Methyl 5-(pyridin-2-yl)-1H-pyrazole-3-carboxylate, 95.0%, 250mg

(S)-4-N-Trityl-2-methyl-piperazine, 98.0%, 1g

(3-BROMO-1-METHYL-1H-1,2,4-TRIAZOL-5-YL)METHANOL, 95%, 5g

(S)-2-Amino-3-(1-methyl-1H-indol-3-yl)propanoic acid, 95.0%, 5g

Jeu de lames de contraste de phase avec objectifs corrigés à l'infini PLPHi IOS 10x et S40x et anneaux de contraste de phase pour 10x/S40x

5',6',7',8'-tetrahydro-3'H-spiro[cyclohexane-1,4'-quinazoline]-2'-thiol, 100mg